Evidence map›Paper›PMID 39917363›Full record

ArticleFrontiers in oncology2024

Impact of social determinants and medical mistrust on parent-child HPV vaccination in economically disadvantaged communities: implications for cancer prevention.

Marcelo M Sleiman, Mary Rose Yockel, Mingqian Liu, Joanne Wendolowski, Lucile L Adams-Campbell, Chiranjeev Dash, Lisa Carter-Bawa, Abraham Aragones, Sahana Arumani, Kenneth P Tercyak

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marcelo M SleimanCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.
Mary Rose YockelCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.
Mingqian LiuCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.
Joanne WendolowskiCenter for Discovery and Innovation, Hackensack Meridian Health-Hackensack University Medical Center, Hackensack, NJ, United States.
Lucile L Adams-CampbellCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.
Chiranjeev DashCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.
Lisa Carter-BawaCenter for Discovery and Innovation, Hackensack Meridian Health-Hackensack University Medical Center, Hackensack, NJ, United States.
Abraham AragonesCenter for Discovery and Innovation, Hackensack Meridian Health-Hackensack University Medical Center, Hackensack, NJ, United States.
Sahana ArumaniCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.
Kenneth P TercyakCancer Prevention and Control Program, Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC, United States.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
NCI NIH HHS P30 CA051008
6 · The paper itself

Abstract

Introduction: Human papillomavirus (HPV) vaccination and intentions, their correlates, and barriers among age-eligible parents and their children living in very economically disadvantaged communities were assessed. Methods: Parents (N=198; 45% Black, 42% Latine, 57% educated <=high school [HS], 74% income <$60k annually) with children ages 10-17 from Washington, DC and Hackensack, NJ were intercepted at community events and surveyed. Results: Among age-eligible parents, 20% were vaccinated against HPV. Comparing vaccinated to unvaccinated parents, those who were non-white (OR=5.5, 95% CI=3.5, 9.4, p<0.001) and with unvaccinated children (OR=8.9, 95% CI=3.7, 23.3, p<0.001) were less likely to be vaccinated themselves. Among children, 37% were vaccinated. Unvaccinated children were more likely to have parents who were non-white (OR=2.7, 95% CI=2.6, 2.8, p<.01), with a <=HS education (OR=3.0, 95% CI=1.52, 6.25, p<.01), and were unvaccinated themselves (OR=10.2, 95% CI=4.01, 28.61, p<.001). Nearly two-thirds (63%) of parents with unvaccinated children expressed an intention to vaccinate within the next year: 48% confirmed receiving advice from a healthcare provider to do so. Common HPV vaccine barriers included lack of information (35%), safety concerns (16%), and perceptions of sexual inactivity (13%). An adjusted model revealed an interaction between parent education and medical mistrust (B=.35, SE=.13, 95% CI=0.09, 0.61, p<.01). For parents with <=HS education, when levels of provider trust were strong, they were more open to vaccinating their children. Conclusions: HPV vaccine prevalence was low among parents and children living in disadvantaged communities. Comprehensive education and intervention to build trust are warranted to prevent the spread of HPV-linked cancers and reduce cancer disparities.

Indexed as

cancer disparitiescancer preventionchildrenfamiliesvaccination

Identifiers

PMID39917363
PMCPMC11798768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.